Intra-Cellular Therapies Inc.
ITCI
ITCI was delisted on the 1st of April, 2025.
74 hedge funds and large institutions have $405M invested in Intra-Cellular Therapies Inc. in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 3 closing their positions.
900% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 3
118% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 11
88% more capital invested
Capital invested by funds: $215M → $405M (+$189M)
57% more funds holding
Funds holding: 47 → 74 (+27)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$22.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.6M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$11.2M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$6.17M |
| 5 |
VAM
Visium Asset Management
New York
|
+$6.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$7.22M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.96M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.24M |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$1.25M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$872K |
ITCI Hedge Fund Activity: Q1 2015 in Review
74 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q1 2015, worth a combined $405M — up 88% from $215M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ITCI positions and 3 closed out — a net gain of 27 holders — while 24 added to existing stakes and 11 trimmed.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $22.4M. The largest seller was Redmile Group, cutting an estimated $7.22M.
- 74 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q1 2015, up from 47 in Q4 2014.
- Funds reported $405M of Intra-Cellular Therapies Inc. stock for Q1 2015, up 88% quarter-over-quarter.
- 30 funds opened new Intra-Cellular Therapies Inc. positions in Q1 2015 and 3 closed out, a net change of +27 holders.
- The largest Intra-Cellular Therapies Inc. buyer in Q1 2015 was Wasatch Advisors, an estimated $22.4M added.
- The largest Intra-Cellular Therapies Inc. seller in Q1 2015 was Redmile Group, an estimated $7.22M sold.
Based on aggregated 13F filings for Q1 2015.